Excision repair cross-complementing gene 1 (ERCC1) protein expression in colorectal cancer

被引：0
作者：
Richman, SD [1 ]
Adlard, JW [1 ]
Seymour, MT [1 ]
Quirke, P [1 ]
机构：
[1] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
[31]   Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma [J].
Peng, Haiying ;
Yao, Shaobo ;
Dong, Qingyu ;
Zhang, Yanxia ;
Gong, Weihong ;
Jia, Zhongyao ;
Yan, Li .
MEDICINE, 2018, 97 (31)
[32]   Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912 [J].
Yamada, Y. ;
Boku, N. ;
Nishina, T. ;
Yamaguchi, K. ;
Denda, T. ;
Tsuji, A. ;
Hamamoto, Y. ;
Konishi, K. ;
Tsuji, Y. ;
Amagai, K. ;
Ohkawa, S. ;
Fujita, Y. ;
Nishisaki, H. ;
Kawai, H. ;
Takashima, A. ;
Mizusawa, J. ;
Nakamura, K. ;
Ohtsu, A. .
ANNALS OF ONCOLOGY, 2013, 24 (10) :2560-2565
[33]   THE ROLE OF THYMIDTYLATE SYNTHASE (TS) AND EXCISION REPAIR CROSS-COMPLEMENTING GROUP 1 (ERCC1) IMMUNOHISTOCHEMICAL EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) PATIENTS TREATED WITH PEMETREXED AND CARBOPLATIN [J].
Zucali, P. A. ;
Destro, A. ;
Ceresoli, G. L. ;
Gianoncelli, L. ;
Lorenzi, E. ;
De Vincenzo, F. ;
Simonelli, M. ;
Giordano, L. ;
Roncalli, M. ;
Santoro, A. .
ANNALS OF ONCOLOGY, 2009, 20
[34]   Changes in expression levels of excision repair cross-complementing group 1 (ERCC1) and dihydropyrimidine dehydrogenase (DPD) after first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer: Results of a multicenter study [J].
Baba, Hideo ;
Baba, Yoshifumi ;
Uemoto, Shinji ;
Oki, Eiji ;
Ikeda, Yasuharu ;
Yamamoto, Masakazu ;
Matsuda, Hiroyuki ;
Shimada, Mitsuo ;
Kokudo, Norihiro .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[35]   Prognostic Value of Excision Repair Cross-complementing Gene 1 Expression for Cisplatin-Based Chemotherapy in Advanced Gastric Cancer [J].
Ozkan, Metin ;
Akbudak, Ismail Hakki ;
Deniz, Kemal ;
Dikilitas, Mustafa ;
Dogu, Gamze Gokoz ;
Berk, Veli ;
Karaca, Halit ;
Er, Ozlem ;
Altinbas, Mustafa .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (01) :181-185
[36]   Customizing cisplatin (cis) based on quantitative excision repair cross-complementing 1 (ERCC1) MRNA expression:: A phase III randomized trial in non-small-cell lung cancer (NSCLC) [J].
Rosell, Rafael ;
Gandara, David ;
Cobo, Manuel ;
Isla, Dolores ;
Massuti, Bartomeu ;
Montes, Ana ;
Sanchez, Jose Miguel ;
Provencio, Mariano ;
Vinolas, Nuria ;
Moran, Teresa .
ANNALS OF ONCOLOGY, 2006, 17
[37]   Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer [J].
Luo, Shan-Shan ;
Liao, Xi-Wen ;
Zhu, Xiao-Dong .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[38]   Expression of ERCC1 protein (excision repair cross complementing group 1) in patients with invasive carcinoma of the uterine cervix (CC) undergoing definitive chemoradiation (CR). [J].
de Souza Caires, Inacelli Queiroz ;
Caires-Lima, Rafael ;
Colombo, Renata ;
Ramos, Clarissa C. A. ;
Machado, Karime Kalil ;
Coelho Siqueira, Sheila Aparecida ;
Carvalho, Heloisa de Andrade ;
Fukushima, Julia Tizue ;
Adra, Thais Rodrigues ;
Hoff, Paulo M. ;
Estevez-Diz, Maria Del Pilar .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[39]   Different Impact of Excision Repair Cross-Complementing Group 1 on Survival [J].
Panasci, Lawrence C. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :E163-E163
[40]   Meta-analysis of excision repair cross complementary gene 1 (ERCC1) expression and platinum chemosensitivity in patients with ovarian cancer [J].
Wu, Jiaohong ;
Li, Renliang ;
Chen, Xinyan ;
Chen, Cong ;
Chen, Haitang ;
Ma, Bidong .
ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) :3428-3435
12345